Pregled bibliografske jedinice broj: 1207057
Rezultati uvođenja tikagrelora u liječenju akutnog infarkta miokarda s ST-elevacijom u Hrvatskoj.
Rezultati uvođenja tikagrelora u liječenju akutnog infarkta miokarda s ST-elevacijom u Hrvatskoj. // Cardiologia croatica, 11 (2016), 10/11; 439-439 (domaća recenzija, članak, znanstveni)
CROSBI ID: 1207057 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Rezultati uvođenja tikagrelora u liječenju akutnog
infarkta miokarda s ST-elevacijom u Hrvatskoj.
(Results of the introduction of ticagrelor in the
treatment of acute ST-elevation myocardial
infarction in Croatia.)
Autori
Babić, Zdravko ; Bulum, Joško ; Brusich, Sandro ; Pintarić, Hrvoje ; Steiner, Robert ; Kristić, Ivica ; Vuksanović, Ilko ; Štambuk, Krešimir ; Šikić, Jozica ; Zekanović, Dražen ; Prvulović, Đeiti ; Kozmar, Damir ; Miličić, Davor
Izvornik
Cardiologia croatica (1848-543X) 11
(2016), 10/11;
439-439
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Bez ključnih riječi
Sažetak
Introduction: PLATO (“Platelet Inhibition and Patient Outcomes”) study demonstrated advantage of ticagrelor in comparison with clopidogrel in acute coronary syndrome in prevention of the cardiovascular death, myocardial infarction and stroke. These results introduced ticagrelor in the European Society of Cardiology and other guidelines for management of acute coronary syndrome.1-3 Patients and Methods: This prospective multicentric observational study compares results of clopidogrel and ticagrelor in the treatment of acute ST- elevation myocardial infarction (STEMI) on national level. Authors investigated acute STEMI patients treated with primary percutaneous coronary intervention (pPCI) in 11 Croatian pPCI centers between June 1st 2015 and May 31st 2016. Patients were divided in three groups: the ticagrelor group, converted group (treatment initiated with clopidogrel and replaced with ticagrelor), and clopidogrel group. Results: In 1947 investigated acute STEMI patients treated with pPCI investigators revealed statistically significant better results of treatment (postprocedural TIMI 3 flow, intrahospital mortality) with statistically significant less clinicaly significant bleeding in those treated with ticagrelor in comparision with those treated only with clopidogrel. Conclusion: These findings may be considered as real-life confirmation of similar results obtained in randomized studies
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
KBC "Sestre Milosrdnice"
Profili:
Krešimir Štambuk
(autor)
Dražen Zekanović
(autor)
Hrvoje Pintarić
(autor)
Joško Bulum
(autor)
Ivica Kristić
(autor)
Robert Steiner
(autor)
Davor Miličić
(autor)
Zdravko Babić
(autor)
Đeiti Prvulović
(autor)
Jozica Šikić
(autor)
Sandro Brusich
(autor)